We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Cancer Immunology – News and Features

News

ImmunoVaccine Technologies to Acquire Immunotope

The acquisition will bring together IVT's signature VacciMax® platform with Immunotope's portfolio of immunotherapeutic antigens and antigen discovery platform.
News

St. Jude Finds Molecule that Could Improve Cancer Vaccines and Therapy for Other Diseases

Investigators have discovered a new signaling molecule that prevents immune responses from running amok and damaging the body.
News

Inovio Biomedical Redirects Strategic Emphasis Toward DNA Vaccines and DNA Delivery

Company expanding R&D to advance its DNA delivery technology and develop proprietary DNA vaccines for cancer and chronic infectious diseases.
News

Inovio Biomedical’s DNA Delivery Technology Enhances Potency of Gene-Based Prostate Cancer Vaccine

Data from a clinical study of DNA-based prostrate cancer demonstrated that Inovio’s DNA delivery technology enhanced the potency of the gene-based vaccine.
News

Geron Scientists and Collaborators Differentiate Human Embryonic Stem Cells into Insulin-Producing Islet-Like Clusters

The study shows that human embryonic stem cells can be transformed into the pancreatic cells that produce insulin that can offer the potential to treat diabetes.
News

Inovio Biomedical to Present DNA Delivery Technology at Drug Delevery Conference

Inovio’s Executive Director will present key aspects of non-viral DNA delivery at Arrowhead Drug Delivery 2007 in San Francisco.
News

Immune response to Cancer Stem Cells may Dictate Cancer’s Course

A new study shows that immunity to cancer stem cells may help protect people with a precancerous condition from developing the full-blown disease.
News

Generex Biotechnology to Test Novel RNAi-Based Immune-Response Strategy in Cancer Patients

Clinical trials to be conducted in Beijing, China with renowned hematologist.
News

Argos Therapeutics Initiate Personalized Immunotherapy Clinical Trial in HIV Patients

Argos Therapeutics initiates a Phase 1/2 clinical trial to test the immunologic activity and safety of its AGS-004 in HIV-infected adults.
News

abc Technologies - Automation Beyond Chemistry

Prominent scientists gathered in Basel to discuss new perspectives and emerging technologies across a broad range of industries.
Advertisement